US 9309326
Readily isolated bispecific antibodies with native immunoglobulin format
granted A61KA61K2039/505
Quick answer
US patent 9309326 (Readily isolated bispecific antibodies with native immunoglobulin format) held by REGENERON PHARMACEUTICALS, INC. expires Mon Apr 07 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- REGENERON PHARMACEUTICALS, INC.
- Grant date
- Tue Apr 12 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 07 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 19
- CPC classes
- A61K, A61K2039/505